This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Ellen R. Strahlman, MD; Stuart L. Fine, MD; Argye Hillis, PhD

Arch Ophthalmol. 1983;101(8):1191-1193.

Abstract
• Patients with senile macular degeneration and exudative maculopathy in one eye and drusen in the second eye have a 3% to 7% risk per year of exudative maculopathy developing in the second eye during the first three years following their initial presentation. The risk is the same for patients with new vessel membranes or other types of exudative maculopathy in the first eye. Second eyes in which exudative changes develop are more likely to have larger numbers of drusen or greater confluence of drusen (or both) initially. The data from this study were analyzed using the Kaplan-Meier technique of estimation, a method (to our knowledge) not previously employed by other investigators. The demographic features of the overall study population, as well as the photographic features associated with increased risk of development of exudative maculopathy, were in agreement with those previously reported.

Author Affiliations
From the Department of Ophthalmology, Wilmer Ophthalmological Institute, The Johns Hopkins Hospital, Baltimore (Drs Strahlman and Fine); and the Research and Education Division, Scott and White Memorial Hospital, Temple, Tex (Dr Hillis).

Footnotes
Accepted for publication Oct 8, 1982.

Reprint requests to Wilmer Ophthalmological Institute, The Johns Hopkins Medical Institutions, Baltimore, MD 21205 (Dr Fine).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Evaluating Retinal Function in Age-Related Maculopathy with the ERG Photostress Test
Binns and Margrain
IOVS 2007;48:2806-2813.
ABSTRACT | FULL TEXT  

Prevalence of reticular pseudodrusen in age-related macular degeneration with newly diagnosed choroidal neovascularisation
Cohen et al.
Br J Ophthalmol 2007;91:354-359.
ABSTRACT | FULL TEXT  

Estimating the yearly number of eyes with treatable neovascular age-related macular degeneration using a direct standardization method and a markov model.
Korobelnik et al.
IOVS 2006;47:4270-4276.
ABSTRACT | FULL TEXT  

Risk of Age-Related Macular Degeneration in Eyes With Macular Drusen or Hyperpigmentation: The Blue Mountains Eye Study Cohort
Wang et al.
Arch Ophthalmol 2003;121:658-663.
ABSTRACT | FULL TEXT  

Passive permeability and outward active transport of fluorescein across the blood-retinal barrier in early ARM
Moldow et al.
Br J Ophthalmol 2001;85:592-597.
ABSTRACT | FULL TEXT  

Macular Pigment and Risk for Age-Related Macular Degeneration in Subjects from a Northern European Population
Beatty et al.
IOVS 2001;42:439-446.
ABSTRACT | FULL TEXT  

The second eye of Japanese patients with unilateral exudative age related macular degeneration
Uyama et al.
Br J Ophthalmol 2000;84:1018-1023.
ABSTRACT | FULL TEXT  

Psychophysical Evidence for Rod Vulnerability in Age-Related Macular Degeneration
Owsley et al.
IOVS 2000;41:267-273.
ABSTRACT | FULL TEXT  

Prophylactic laser treatment in early age related maculopathy reduced the incidence of exudative complications
Frennesson and Nilsson
Br J Ophthalmol 1998;82:1169-1174.
ABSTRACT | FULL TEXT  

Bilateral involvement by age related maculopathy lesions in a population
Wang et al.
Br J Ophthalmol 1998;82:743-747.
ABSTRACT | FULL TEXT  

Risk Factors for Choroidal Neovascularization in the Second Eye of Patients With Juxtafoveal or Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
Macular Photocoagulation Study Group
Arch Ophthalmol 1997;115:741-747.
ABSTRACT  

Laser Treatment in Subjects With High-risk Clinical Features of Age-related Macular Degeneration: Posterior Pole Appearance and Retinal Function
Guymer et al.
Arch Ophthalmol 1997;115:595-603.
ABSTRACT  

Characteristics of Drusen and Bruch's Membrane in Postmortem Eyes With Age-Related Macular Degeneration
Spraul and Grossniklaus
Arch Ophthalmol 1997;115:267-273.
ABSTRACT  

Five-Year Incidence and Disappearance of Drusen and Retinal Pigment Epithelial Abnormalities: Waterman Study
Bressler et al.
Arch Ophthalmol 1995;113:301-308.
ABSTRACT  

Five-Year Follow-up of Fellow Eyes of Patients With Age-Related Macular Degeneration and Unilateral Extrafoveal Choroidal Neovascularization
Macular Photocoagulation Study Group
Arch Ophthalmol 1993;111:1189-1199.
ABSTRACT  

Vision Screening in a Primary Care Setting: A Missed Opportunity?
Strahlman et al.
Arch Intern Med 1990;150:2159-2164.
ABSTRACT  

Relationship of Drusen and Abnormalities of the Retinal Pigment Epithelium to the Prognosis of Neovascular Macular Degeneration
Bressler et al.
Arch Ophthalmol 1990;108:1442-1447.
ABSTRACT  

Monozygotic Twins With Age-Related Macular Degeneration
Meyers and Zachary
Arch Ophthalmol 1988;106:651-653.
ABSTRACT  

Peripheral Retinal Function in Age-Related Macular Degeneration
Sunness et al.
Arch Ophthalmol 1985;103:811-816.
ABSTRACT  

Cellular Mechanisms of Resolution of Drusen After Laser Coagulation: An Experimental Study
Duvall and Tso
Arch Ophthalmol 1985;103:694-703.
ABSTRACT